GlutathioneS-Transferase P1: Gene Sequence Variation and Functional Genomic Studies
- 15 June 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (12), 4791-4801
- https://doi.org/10.1158/0008-5472.can-07-6724
Abstract
Glutathione S-transferase P1 (GSTP1) is of importance for cancer research because of its role in detoxifying carcinogens, activating antineoplastic prodrugs, metabolizing chemotherapeutic agents, and its involvement in cell cycle and apoptosis regulation. Two common GSTP1 genetic polymorphisms have been studied extensively. However, the full range of GSTP1 genetic variation has not been systematically characterized in the absence of disease pathology. We set out to identify common GSTP1 polymorphisms in four ethnic groups, followed by functional genomic studies. All exons, splice junctions, and the 5′-flanking region of GSTP1 were resequenced using 60 DNA samples each from four ethnic groups. The 35 single-nucleotide polymorphisms (SNP) identified included six nonsynonymous SNPs and 17 previously unreported polymorphisms. GSTP1 variant allozymes were then expressed in COS-1 cells, and five displayed significantly altered levels of enzyme activity. One decreased to 22% of the wild-type (WT) activity. Four variant allozymes had Km values that differed significantly from that of the WT, and five showed altered levels of immunoreactive protein compared with WT, with a significant correlation (r = 0.79, P < 0.007) between levels of immunoreactive protein and enzyme activity in these samples. In the Mexican American population, five linked SNPs were significantly associated with GSTP1 mRNA expression, one of which was found by electrophoretic mobility shift assay to alter protein binding. These studies have identified functionally significant genetic variation, in addition to the two frequently studied GSTP1 nonsynonymous SNPs, that may influence GSTP1's contribution to carcinogen and drug metabolism, and possibly disease pathogenesis and/or drug response. [Cancer Res 2008;68(12):4791–801]Keywords
Other Versions
This publication has 56 references indexed in Scilit:
- Genetic diversity and function in the human cytosolic sulfotransferasesThe Pharmacogenomics Journal, 2006
- Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based ChemotherapyClinical Cancer Research, 2006
- Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2–ASK1 signalsOncogene, 2006
- Human phenylethanolamine N‐methyltransferase pharmacogenomics: gene re‐sequencing and functional genomicsJournal of Neurochemistry, 2005
- Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndromeJournal of Medical Genetics, 2005
- Faster cyclic loess: normalizing RNA arrays via linear modelsBioinformatics, 2004
- Score Tests for Association between Traits and Haplotypes when Linkage Phase Is AmbiguousAmerican Journal of Human Genetics, 2002
- Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancerOncogene, 1999
- Structure-activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105Journal of Molecular Biology, 1998
- Activity of Four Allelic Forms of Glutathione S-Transferase hGSTP1-1 for Diol Epoxides of Polycyclic Aromatic HydrocarbonsBiochemical and Biophysical Research Communications, 1997